Chronic Lymphocytic Leukemia

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia (often shortened to CLL) is a type of blood cancer that starts in white blood cells called lymphocytes. Lymphocytes are part of the immune system, the body’s network for fighting infection. In chronic lymphocytic leukemia, the bone marrow — the spongy tissue inside bones where blood cells are made — produces abnormal lymphocytes that do not work properly and do not die when they should. Over time, these abnormal cells build up in the blood, bone marrow, lymph nodes (small bean-shaped glands found throughout the body), and sometimes the spleen and liver.

The word “chronic” means the disease usually develops slowly, often over years. This makes it different from acute leukemias, which progress quickly and typically need urgent treatment. Many people with chronic lymphocytic leukemia have no symptoms at all when the disease is first found; in many cases it is discovered by chance on a routine blood test done for another reason.

Chronic lymphocytic leukemia is one of the most common leukemias in adults in Western countries. It mainly affects older adults — most people are diagnosed after age 60, and it is rare in people under 40. It is slightly more common in men than in women. A closely related condition called small lymphocytic lymphoma (SLL) involves the same type of abnormal cell but is found mostly in the lymph nodes rather than the blood; doctors generally consider CLL and SLL to be different forms of the same disease.

Symptoms of chronic lymphocytic leukemia

Many people have no chronic lymphocytic leukemia symptoms for a long time, especially in the early stages. When symptoms do appear, they tend to develop gradually. Common signs and symptoms include:

• Painless swollen lymph nodes, most often in the neck, armpits, or groin
• Persistent tiredness (fatigue) that does not improve with rest
• Frequent or lingering infections, because the abnormal lymphocytes cannot fight germs effectively
• Unintentional weight loss
• Fever without an obvious infection
• Night sweats that soak clothing or bedding
• A feeling of fullness or discomfort in the upper left abdomen, which can happen when the spleen becomes enlarged
• Easy bruising or bleeding, which can occur if the number of platelets (blood cells that help clotting) falls
• Shortness of breath or paleness, which can occur with anemia (a low red blood cell count)

Symptoms often relate to the stage of the disease. In early-stage disease, the main finding may simply be a raised lymphocyte count on a blood test, sometimes with mildly enlarged lymph nodes. As the disease advances, the crowding of the bone marrow by abnormal cells can reduce the production of healthy red blood cells and platelets, leading to anemia, bleeding problems, and more frequent infections. Doctors sometimes group fever, drenching night sweats, and significant weight loss together as “B symptoms,” and their presence can influence decisions about when to start treatment.

It is important to remember that all of these symptoms can also be caused by many less serious conditions. Having one or more of them does not mean you have leukemia, but persistent symptoms should always be checked by a doctor.

Causes and risk factors

The exact chronic lymphocytic leukemia causes are not fully understood. The disease begins when genetic changes (mutations) occur in the DNA of a developing lymphocyte. DNA is the set of instructions inside every cell that tells it how to grow, divide, and die. These mutations allow the abnormal cell to multiply and survive longer than it should. In most cases, doctors cannot say why these changes happened in a particular person.

Although the cause is usually unknown, several factors are known to increase the risk of developing chronic lymphocytic leukemia:

• Age: the risk rises steadily with age, and most people are diagnosed in their 60s or 70s.
• Sex: men are somewhat more likely to develop CLL than women.
• Family history: having a first-degree relative (a parent, sibling, or child) with CLL or certain other blood cancers increases the risk. This suggests inherited factors play a role in some families, although most people with CLL have no affected relatives.
• Ethnic and geographic background: CLL is more common in people of European descent and less common in people of East Asian descent.
• Certain chemical exposures: exposure to some chemicals, including certain herbicides and pesticides such as those studied in relation to Agent Orange, has been linked to a higher risk in some groups.

Some people are found to have a condition called monoclonal B-cell lymphocytosis (MBL), in which a small population of abnormal lymphocytes is present in the blood without meeting the criteria for leukemia. MBL can precede chronic lymphocytic leukemia, but many people with MBL never develop the disease.

Importantly, chronic lymphocytic leukemia is not contagious — it cannot be passed from person to person — and it is not caused by anything a person clearly did or failed to do. Lifestyle factors such as diet appear to play, at most, a minor role.

Diagnosis

Chronic lymphocytic leukemia diagnosis usually begins with a simple blood test. Because the disease often causes no symptoms early on, it is frequently detected when a routine complete blood count (CBC) — a test that measures the different types of cells in the blood — shows an unusually high number of lymphocytes.

To confirm the diagnosis, doctors typically use the following tests:

• Complete blood count with differential: this measures red blood cells, white blood cells, and platelets, and shows whether the lymphocyte count is persistently elevated.
• Blood smear: a drop of blood is examined under a microscope to look at the appearance of the cells. In CLL, characteristic fragile cells called “smudge cells” are often seen.
• Flow cytometry (immunophenotyping): this is the key confirmatory test. A machine analyzes proteins on the surface of the blood cells to show that the excess lymphocytes are a single abnormal population with the typical pattern of CLL. In most cases, this test on a blood sample is enough to confirm the diagnosis without a bone marrow procedure.
• Genetic and molecular tests: tests such as FISH (fluorescence in situ hybridization, which looks for specific chromosome changes) and analysis of genes such as TP53 and IGHV help doctors estimate how the disease is likely to behave and which treatments may work best.
• Bone marrow biopsy: a small sample of marrow is taken, usually from the hip bone, using a needle under local anesthetic. This is not always required for diagnosis but may be done in certain situations, for example to investigate low blood counts.
• Imaging: scans such as computed tomography (CT) may be used to assess enlarged lymph nodes or an enlarged spleen. In selected situations — for example, if doctors suspect the disease has transformed into a faster-growing lymphoma — advanced imaging such as PET-CT imaging may be recommended to identify the most active areas of disease.

Once the diagnosis is confirmed, doctors assign a stage. Two systems are widely used: the Rai system (common in the United States) and the Binet system (common in Europe). Both are based on the lymphocyte count, the number of enlarged lymph node areas, whether the spleen or liver is enlarged, and whether anemia or low platelets are present. Staging, together with the genetic test results, helps guide decisions about whether and when treatment is needed.

Treatment options

Chronic lymphocytic leukemia treatment is highly individualized. Unlike many cancers, CLL does not always need to be treated right away, and starting treatment early in people without symptoms has not been shown to help them live longer. Care for this condition is usually coordinated by hematologists and medical oncologists; at Acibadem, for example, it is managed within the Medical Oncology Department together with hematology specialists.

Watchful waiting (active surveillance)

For many people with early-stage disease and no significant symptoms, the standard approach is watchful waiting, also called active surveillance. This means regular check-ups and blood tests — often every few months — without any active treatment. Treatment is started only if the disease begins to progress, for example if blood counts worsen, lymph nodes or the spleen enlarge significantly, or troubling symptoms such as marked fatigue, fevers, night sweats, or weight loss develop. Watchful waiting can feel unsettling, but it is an evidence-based strategy, not a lack of care.

Targeted therapy

When treatment is needed, targeted drugs are now the main option in many cases. These are medicines that block specific proteins the leukemia cells depend on to survive. Two important groups are:

• BTK inhibitors (drugs that block an enzyme called Bruton tyrosine kinase), which are taken as pills, often on a continuous basis.
• BCL-2 inhibitors (drugs that block a protein that helps leukemia cells avoid dying), which are often given for a fixed period, sometimes combined with antibody treatment.

Your doctor may recommend one type over another based on the genetic features of your disease, your other health conditions, and possible side effects.

Monoclonal antibodies and immunotherapy

Monoclonal antibodies are laboratory-made proteins that attach to markers on the surface of leukemia cells and help the immune system destroy them. Antibodies directed against a marker called CD20 are commonly combined with targeted drugs or, less often now, with chemotherapy.

Chemotherapy

Chemotherapy uses medicines that kill rapidly dividing cells. It was the standard treatment for CLL for many years, usually combined with an antibody (chemoimmunotherapy). Its role has decreased as targeted therapies have become available, but it may still be considered in selected situations.

Cellular therapy and stem cell transplantation

For disease that returns or stops responding to standard treatments, additional options may be considered. CAR-T cell therapy is a form of immunotherapy in which a patient’s own immune cells are collected, modified in a laboratory to recognize the leukemia, and returned to the body; its use in CLL is generally limited to specific situations and specialized centers. An allogeneic stem cell transplant — replacing the patient’s bone marrow with healthy donor cells — is a potentially curative but intensive procedure reserved for a small number of carefully selected patients, because it carries significant risks.

Supportive care

Because CLL weakens the immune system, supportive care is an important part of treatment. This can include vaccinations (usually non-live vaccines), prompt treatment of infections, medicines to boost antibody levels in selected patients, and blood transfusions if counts are very low. Surgery plays almost no role in treating CLL itself, although removal of the spleen is occasionally considered for specific complications. A broader overview of how blood cancers are managed is available on the leukemia and lymphoma treatment page.

Living with chronic lymphocytic leukemia and outlook

The outlook for people with chronic lymphocytic leukemia varies widely. Some people live for many years — even decades — without ever needing treatment, while others have a more aggressive form of the disease that requires therapy sooner and responds less predictably. Genetic features of the leukemia cells, the stage at diagnosis, age, and overall health all influence prognosis, which is why doctors avoid giving one-size-fits-all predictions. Modern targeted treatments have improved outcomes considerably, and many people with CLL live full, active lives, but the disease is generally considered manageable rather than curable with standard therapies.

Day to day, living well with CLL often involves:

• Keeping regular follow-up appointments and blood tests, even when you feel well.
• Reducing infection risk through hand hygiene, recommended vaccinations, and seeking care early when infections start, since even minor infections can become serious.
• Skin protection and cancer screening: people with CLL have a higher risk of other cancers, particularly skin cancer, so sun protection and routine screening are often advised.
• Managing fatigue with paced activity, gentle exercise, and good sleep habits.
• Looking after emotional health: living with a chronic cancer, especially during watchful waiting, can cause anxiety. Counseling, support groups, and honest conversations with your care team can help.

Some people with CLL eventually experience a change called Richter transformation, in which the disease turns into a faster-growing lymphoma. This is uncommon, but it is one reason ongoing monitoring matters even in stable disease.

Frequently asked questions

What is chronic lymphocytic leukemia in simple terms?

It is a slow-growing cancer of the blood and bone marrow in which the body makes too many abnormal white blood cells called lymphocytes. These cells build up over time and can crowd out healthy blood cells and weaken the immune system. It mainly affects older adults and often causes no symptoms at first.

Can chronic lymphocytic leukemia be cured?

With standard treatments, CLL is generally considered a controllable, long-term condition rather than a curable one. Treatments can keep the disease in remission — meaning no or very little detectable disease — often for long periods. A donor stem cell transplant can potentially cure the disease in some patients, but it is an intensive procedure used only in selected cases. Your doctor can explain which goals are realistic in your situation.

How serious is chronic lymphocytic leukemia?

Seriousness varies from person to person. Many people have a slow-moving form that may never require treatment, while others have disease that progresses faster and needs therapy. Genetic testing of the leukemia cells helps doctors estimate how the disease is likely to behave. Even in slower forms, the weakened immune system means infections need to be taken seriously.

What are the first symptoms of chronic lymphocytic leukemia?

Often there are none, and the disease is found on a routine blood test. When early chronic lymphocytic leukemia symptoms do occur, they commonly include painless swollen lymph nodes in the neck, armpit, or groin, unusual tiredness, and infections that keep coming back. Fevers, night sweats, and unexplained weight loss can also occur, usually as the disease advances.

Why do doctors sometimes wait instead of treating right away?

Studies have shown that treating early-stage CLL in people without symptoms does not help them live longer, while treatment can cause side effects. Watchful waiting means the disease is monitored closely with regular check-ups, and treatment is started as soon as it is genuinely needed. This approach is standard practice worldwide, not a delay in care.

Can you live a normal life with chronic lymphocytic leukemia?

Many people can. Those with stable, early-stage disease often continue working, traveling, and exercising with few limitations, apart from regular monitoring and sensible precautions against infection. People receiving treatment may need to adjust their routines around side effects. Your care team can advise you on activity, travel, and vaccinations based on your individual condition.

Is chronic lymphocytic leukemia hereditary?

Most cases are not inherited, and most people with CLL have no affected relatives. However, having a close family member with CLL or a related blood cancer does modestly increase the risk, which suggests inherited factors play a role in some families. Routine screening of family members is not generally recommended, but you can discuss any family history concerns with your doctor.

When to see a doctor

See a doctor promptly if you notice possible signs of chronic lymphocytic leukemia, such as swollen lymph nodes that persist for more than a couple of weeks, ongoing unexplained fatigue, repeated infections, drenching night sweats, or unintentional weight loss. If you have already been diagnosed with CLL, contact your care team without delay — or seek urgent care — if you experience any of the following red-flag warning signs:

• Fever of 38°C (100.4°F) or higher, chills, or other signs of infection, especially during treatment, because infections can worsen quickly when the immune system is weakened
• Unusual bleeding or bruising, such as nosebleeds that will not stop, blood in the urine or stool, or tiny red spots on the skin
• Severe or rapidly worsening shortness of breath, chest pain, or a racing heartbeat
• Rapidly enlarging lymph nodes, or a node that becomes painful, hard, or fixed in place
• Marked paleness, dizziness, or extreme weakness, which can signal severe anemia
• New drenching night sweats, high fevers, or fast weight loss, which can indicate the disease is progressing or changing
• Severe abdominal pain or a sudden feeling of fullness, which may relate to an enlarged spleen

These symptoms do not always mean the leukemia is progressing, but they should be evaluated quickly. Early assessment gives your medical team the best chance to treat infections and other complications before they become serious.